Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

131.50p
   
  • Change Today:
      3.00p
  • 52 Week High: 137.50p
  • 52 Week Low: 102.50p
  • Currency: UK Pounds
  • Shares Issued: 106.23m
  • Volume: 13,771
  • Market Cap: £139.69m
  • RiskGrade: 76

Cello Health reports solid growth in 'strong' first half

By Iain Gilbert

Date: Thursday 18 Jul 2019

LONDON (ShareCast) - (Sharecast News) - Advisory group Cello Health anticipates that full-year earnings will "at least be in line with current expectations" after recording growth across the whole business.
Cello said on Thursday that it had experienced a "strong first six months of the year", with good like-for-like growth in overall net revenues and headline profit before tax.

As a result, Cello witnessed "strong growth" in headline earnings per share, leaving it confident of achieving "a successful result in 2019".

Cello Signal, the company's marketing agency, revealed details of its solid start to the year, "with a performance similar to that in the first half of 2018".

The AIM-listed outfit also ended the period with a strong balance sheet, resulting in a net cash position at the end of June.

Looking forward, Cello said: "The group continues to assess suitable acquisitions in line with the strategic objective of further growing the Cello Health brand in the US in particular."

As of 0945 BST, Cello shares had sparked up 4.20% to 124p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 131.50p
Change Today 3.00p
% Change 2.33 %
52 Week High 137.50p
52 Week Low 102.50p
Volume 13,771
Shares Issued 106.23m
Market Cap £139.69m
RiskGrade 76

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
58.76% below the market average58.76% below the market average58.76% below the market average58.76% below the market average58.76% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Price Trend
29.80% above the market average29.80% above the market average29.80% above the market average29.80% above the market average29.80% above the market average
28.21% above the sector average28.21% above the sector average28.21% above the sector average28.21% above the sector average28.21% above the sector average
Income
16.72% above the market average16.72% above the market average16.72% above the market average16.72% above the market average16.72% above the market average
46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average
Growth
31.14% below the market average31.14% below the market average31.14% below the market average31.14% below the market average31.14% below the market average
47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 13-Dec-2019

Time Volume / Share Price
14:10 89 @ 130.25p
13:36 2,267 @ 131.76p
11:03 4,225 @ 130.75p
10:51 3,238 @ 128.55p
09:28 1,276 @ 128.55p

Cello Health Key Personnel

CEO Mark Scott

Top of Page